Underrecognized signs and symptoms of lung cancer can delay detection and diagnosis. Awareness may help increase the chance of finding the disease before it spreads. Explore how we’re helping to break down the barriers standing in the way of early detection through Mission Lung Cancer: merck.us/47Yrq2I #LungCancerAwarenessMonth
About us
At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.merck.com. This site is intended for residents of the United States and Canada and their territories only. FLS: http://merck.us/3TKXNuZ
- Website
-
http://merck.us/2J2xAUh
External link for Merck
- Industry
- Pharmaceutical Manufacturing
- Company size
- 10,001+ employees
- Headquarters
- Rahway, New Jersey
- Type
- Public Company
- Specialties
- Pharmaceutical
Locations
-
Primary
Get directions
126 E Lincoln Ave
P.O. Box 2000
Rahway, New Jersey 07065, US
-
Get directions
351 N Sumneytown Pike
North Wales, PA 19454, US
Employees at Merck
Updates
-
Our manufacturing team’s commitment to patients is at the foundation of everything we do. At our Elkton facility, our agility enables us to pivot to meet evolving health needs, and our recent $3 billion investment in a new Center of Excellence for Pharmaceutical Manufacturing will empower us to bring innovative therapies to patients even faster.
-
We’re presenting important new research from our expanding #hematology pipeline at #ASH25. Learn more about the novel approaches we’re exploring for patients with hematologic neoplasms and malignancies: http://merck.us/4a9UcP2
-
We’re proud to announce the #FDA approval of two new treatment combinations for certain patients with muscle-invasive #BladderCancer (MIBC). This milestone, in collaboration with Pfizer and Astellas Pharma, is an important step in bladder cancer care for more patients. Learn more: http://merck.us/4pnYZkr
-
The American Chemical Society has awarded our company a National Historic Chemical Landmark for our landmark research developing a medication to help lower LDL cholesterol. This designation recognizes the pioneering science that began with our team’s discovery and paved the way for first-in-class and follow-on medicines. Merck has been integral to the transformation of the treatment of cardiovascular disease. Learn more about our new designation and the science behind it: http://merck.us/4iahc2s
-
-
Our mission is to pursue bold science wherever it comes from, to harness the potential of benefitting as many patients as possible. Science and value-driven business development remains a top priority, and we continue to assess opportunities with urgency and an eye toward driving near- and long-term growth. http://merck.us/4pEEdxh
-
Across our company, we are united in supporting the pulmonary arterial hypertension (PAH) community. PAH occurs due to the narrowing of arteries in the lungs, restricting the flow of blood through the lungs and raising the blood pressure in the lungs. We’re driven by our shared mission. Learn more from the real stories and everyday realities of those living with this disease: http://merck.us/3LFBPaO #PHAwarenessMonth
-
We are excited to announce positive topline Phase 3 results for our investigational oral #HIV treatment in treatment-naïve adults with HIV-1 infection: http://merck.us/4o5EhVk
-
We’re proud to announce the European Commission has approved a new route of administration for a treatment option for patients with certain types of #cancer in the EU. Learn more here: http://merck.us/4oM5ldk
-
-
We’re pleased to announce topline results from our Phase 2 study in a type of pulmonary hypertension (#PH). Learn more here: http://merck.us/3XA4pNf